These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Fixation and central visual field after perifoveal krypton laser treatment of subfoveal neovascularizations. Schneider U; Kuck H; Kreissig I Eur J Ophthalmol; 1993; 3(4):193-200. PubMed ID: 7511450 [TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of subretinal neovascular membrane. Park KH; Yu HG; Yu YS; Park KH; Chung H; Lee J Korean J Ophthalmol; 1999 Jun; 13(1):30-5. PubMed ID: 10761394 [TBL] [Abstract][Full Text] [Related]
44. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Ninomiya Y; Lewis JM; Hasegawa T; Tano Y Am J Ophthalmol; 1996 Nov; 122(5):613-21. PubMed ID: 8909200 [TBL] [Abstract][Full Text] [Related]
45. Visual acuity and scar size in eyes with age-related subfoveal choroidal neovascular lesions, 30 months after radiation therapy. Bergnik GJ; Hoyng CB; van der Maazen RW; Deutman AF; van Daal WA Doc Ophthalmol; 1996-1997; 92(1):61-75. PubMed ID: 9181334 [TBL] [Abstract][Full Text] [Related]
46. Results of argon laser photocoagulation in presumed ocular histoplasmosis. Klein ML; Fine SL; Patz A Am J Ophthalmol; 1978 Aug; 86(2):211-7. PubMed ID: 567434 [TBL] [Abstract][Full Text] [Related]
48. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Ohji M; Fujikado T; Kusaka S; Hayashi A; Hosohata J; Ikuno Y; Sawa M; Kubota A; Hashida N; Tano Y Am J Ophthalmol; 2001 Dec; 132(6):888-96. PubMed ID: 11730654 [TBL] [Abstract][Full Text] [Related]
49. Indocyanine green angiography-guided photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment. Lim JI; Aaberg TM; Capone A; Sternberg P Am J Ophthalmol; 1997 Apr; 123(4):524-32. PubMed ID: 9124249 [TBL] [Abstract][Full Text] [Related]
50. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Fine SL; Owens SL; Haller JA; Knox DL; Patz A Am J Ophthalmol; 1981 Mar; 91(3):318-22. PubMed ID: 6163361 [TBL] [Abstract][Full Text] [Related]
51. Surgical management of subfoveal neovascularization in children. Sears J; Capone A; Aaberg T; Lewis H; Grossniklaus H; Sternberg P; DeJuan E Ophthalmology; 1999 May; 106(5):920-4. PubMed ID: 10328390 [TBL] [Abstract][Full Text] [Related]
52. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol; 1983 Sep; 101(9):1347-57. PubMed ID: 6193771 [TBL] [Abstract][Full Text] [Related]
53. Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Guyer DR; Fine SL; Maguire MG; Hawkins BS; Owens SL; Murphy RP Arch Ophthalmol; 1986 May; 104(5):702-5. PubMed ID: 2423062 [TBL] [Abstract][Full Text] [Related]
54. Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration. Gabel-Pfisterer A; Laue J; Heimann H; Jandeck C; Kellner U; Bornfeld N; Foerster MH Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):350-4. PubMed ID: 14714187 [TBL] [Abstract][Full Text] [Related]
55. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Hawkins BS; Miskala PH; Bass EB; Bressler NM; Childs AL; Mangione CM; Marsh MJ; Arch Ophthalmol; 2004 Nov; 122(11):1616-28. PubMed ID: 15534122 [TBL] [Abstract][Full Text] [Related]